A diet drink, a sugar-free biscuit and a sweetener sachet can solve different problems—and raise different questions. Follow the ingredients, the portion and the evidence before trusting the promise on the front.
The sugar-free aisle contains several different stories
A shopper reaches for a sugar-free biscuit, another chooses a diet drink, and a third adds a stevia sachet to tea. The packets seem to promise the same change. Their ingredient lists may describe quite different products.
Ordinary sugars, high-intensity sweeteners and sugar alcohols are separate groups. High-intensity ingredients can supply sweetness in very small quantities. Polyols, such as sorbitol and erythritol, can also provide bulk and texture. Neither group tells you everything about the finished food.
That matters when a product needs more than a sweet taste. A biscuit still needs structure; a chocolate still contains other ingredients. Removing one ingredient does not remove the need to read the rest of the label. The branching illustration maps ingredient families. Its ribbon widths do not measure sales, consumption or health effects.
Evidence and definitions
Sugar-free and no added sugar answer different questions
In India, FSSAI’s Advertising and Claims Regulations set a sugars-free threshold of no more than 0.5 grams per 100 grams of a solid food or per 100 millilitres of a liquid. That is a concentration rule, not a guarantee that every pack contains precisely zero sugar.
A no-added-sugars claim concerns how the product was made. The rules exclude adding sugars and certain sugar-containing ingredients or substitutes; they also address processes that increase sugars. Where sugars occur naturally, the label must make that clear. Fruit or milk ingredients can therefore matter even when the front says no added sugar.
The chart uses the Indian sugars-free boundary only as an arithmetic example: 0.5 grams per 100 millilitres corresponds to 1.25 grams in 250 millilitres. It does not describe a tested drink. Other countries use different claim rules, so an imported label needs its own context.
WHO’s weight advice is not a toxicity verdict
Two questions often become tangled: can an ingredient be used within an assessed safety limit, and will regularly choosing it improve long-term health? A food regulator and a weight-management guideline may be answering different questions.
WHO’s 2023 guideline conditionally recommends against using non-sugar sweeteners for long-term weight control or reducing noncommunicable-disease risk. The conditional wording reflects uncertainty, including confounding in observational research. For example, people already concerned about weight or illness may be more likely to choose diet products.
The guideline excludes people with pre-existing diabetes from its recommendation and does not cover polyols. It also does not replace toxicological assessments of individual sweeteners. Readers should not turn it into either a blanket declaration of poisoning or a promise that a sweetener is an effective long-term weight treatment.
Evidence and definitions
A natural-sounding name does not describe the whole sachet
The prominent ingredient on the front may not be the ingredient present in the greatest quantity. A high-intensity sweetener can be blended with another substance to make a small portion easier to measure. Check the ingredients rather than assuming that a sachet is pure stevia or pure monk-fruit extract.
Polyols deserve their own reading. They generally provide fewer calories and produce a smaller blood-glucose change than ordinary sugars, but they are not interchangeable. Large amounts of some can cause digestive effects. A food containing them may still contain other carbohydrates.
There is no useful universal league table headed natural equals safest. Ingredient identity, amount, the whole product and the person’s circumstances all matter. The FDA also identifies a specific exception for aspartame: people with phenylketonuria need to avoid or restrict its phenylalanine. A broad marketing category cannot replace that ingredient-specific information.
Evidence and definitions
A small trial can reveal a mechanism without settling a lifetime
A 2022 randomised study in Cell enrolled 120 healthy adults. It compared four non-nutritive sweeteners with controls over two weeks of supplementation. Responses varied; saccharin and sucralose affected glycaemic responses at group level in that experiment, and the researchers investigated microbiome-related mechanisms.
Those details are essential. A short intervention in selected adults is not a measurement of every consumer, every sweetener or lifelong disease risk. It does not justify saying that every diet drink causes diabetes. It does show why treating all sweeteners as biologically identical is too simple.
When a dramatic claim reaches the dinner table, ask what was actually measured. Was it a blood marker, a glucose response, a diagnosis years later, or a laboratory mechanism? The illustration separates those questions rather than inventing a single risk score.
Evidence and definitions
Erythritol headlines need the same careful separation
Research reported in 2023 linked higher blood erythritol with subsequent cardiovascular events in people undergoing cardiac evaluation. The investigators also ran laboratory experiments and a small ingestion study in eight volunteers. Together, those strands raised a plausible concern that warranted further investigation.
They did not establish how much risk a particular consumer acquires by eating a particular sugar-free food. Blood erythritol is not a simple diary of dietary intake: the body can make it too. An association, a mechanism and a long-term dietary trial are different forms of evidence. EFSA’s December 2023 review likewise found that the available evidence did not demonstrate a dietary cause-and-effect relationship with cardiovascular disease; it called for further clarification.
Aspartame illustrates a separate distinction. In 2023, IARC identified a possible carcinogenic hazard on limited evidence, while JECFA retained its acceptable daily intake of 0–40 milligrams per kilogram of body weight. Hazard identification and risk at a given exposure are different assessments. That limit is not a suggested daily target.
Read the whole portion, including the sodium line
A reduced-sugar food does not automatically become a reduced-sodium food. If the question is salt intake, read sodium. If it is carbohydrate intake, read total carbohydrate and sugars alongside the ingredients. A front-of-pack claim cannot answer both questions.
Use the calculator with a real sodium label expressed per 100 grams and a weighed portion. For example, an illustrative label of 800 milligrams per 100 grams gives 480 milligrams in 60 grams. That is arithmetic, not a claim about a named biscuit or a forecast of blood pressure.
For an everyday decision, compare like-sized portions, consider what the product replaces, and avoid treating sugar-free as an unlimited allowance. People managing diabetes or a medically restricted diet need advice fitted to that condition. A useful label helps a decision; it does not make the decision on its own.
Evidence and definitions
The figures behind the story
| Measure | Value | Unit | Reference | Source URL |
|---|---|---|---|---|
| Indian sugars-free boundary | 0.5 | g per 100 g or 100 ml | FSSAI claim threshold, not guaranteed zero | Source |
| Microbiome trial sample | 120 | adults | Suez et al. 2022; selected healthy adults | Source |
| Microbiome supplementation period | 2 | weeks | Short intervention; not lifetime follow-up | Source |
| Erythritol ingestion substudy | 8 | volunteers | NIH account of 2023 research; not a disease-outcome trial | Source |
| JECFA aspartame ADI upper boundary | 40 | mg/kg body weight/day | 2023 assessment; not a recommended intake | Source |
How this story was built
This is an explanatory compilation, not a new clinical study. All illustrations and motion paths were written for this NINE145 package intended to help people like us. Decorative flow speeds, particle counts and ribbon widths used are not measured biological quantities. Published numerical comparisons use their stated units and context. No individual risk or diagnosis is calculated. This is general information, not a personal treatment plan.



